Mylan

ETOPOSIDE

Manufacturer:

Mylan

Etoposide HCPCS:

J8560

HCPCS Code Descriptor:

Etoposide; oral, 50 mg

Category:

J Code

Etoposide NDCs:

00378-3266-94

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Etoposide:

ETOPOSIDE is an Oncology drug manufactured by Mylan and administered via the Oral route of administration. The J Code: J8560 is aligned to the drug ETOPOSIDE.

ACCESS PRICING AND MORE BY REGISTERING

J8560 Added Date:

January 1, 1995

J8560 Effective Date:

January 1, 1997

J8560 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Etoposide billing and coding information.
Etoposide patient assistance information can be found through KabiCare at the URL: https://kabicare.us/
ETOPOSIDE prescribing information can be found at the link below:
Information regarding ETOPOSIDE’s side effects can be found at MedlinePlus